Join the 'Vagifem' group to help and get support from people like you. How it works
Vagifem Blog
| Tweet |
Birth Control Pills, HRT Tied to Digestive Ills
Posted 7 days ago by Drugs.com
MONDAY, May 21 – The use of oral contraceptives by younger women or hormone therapy by older women may be linked with inflammatory bowel disease, new research indicates. Birth control pills are associated with a higher risk for Crohn's disease, said researcher Dr. Hamed Khalili, a clinical and research fellow of gastroenterology at Massachusetts General Hospital in Boston. Crohn's causes inflammation of the lining and wall of the large or small intestine, or both. The lining can become so inflamed it bleeds. Hormone replacement therapy taken by some women after menopause is linked with ulcerative colitis, the study found. It is a disease of the colon (large intestine) or rectum. It causes diarrhea, abdominal cramping and rectal bleeding. Khalili presented the findings Sunday at the Digestive Disease Week meeting, in San Diego. Of the two links they found, Khalili said, the association ... Read more
Related support groups: Birth Control, Contraception, Sprintec, Mirena, Tri-Sprintec, Provera, Implanon, Loestrin 24 Fe, Plan B, Yasmin, Ortho Tri-Cyclen, Estradiol, NuvaRing, Lutera, Ocella
Long-Term Estrogen Therapy Does Up Breast Cancer Risk: Study
Posted 2 Apr 2012 by Drugs.com
SUNDAY, April 1 – Several weeks after a study suggested that women who take estrogen-only hormone replacement to treat menopause symptoms may be at lower risk for developing breast cancer, another, much-larger study finds that when used for longer than 10 years, estrogen-only regimens actually raise a woman's long-term risk for breast cancer. The new study was funded by the National Cancer Institute, part of the U.S. National Institutes of Health, whereas the previous one was partially funded by drug manufacturer Wyeth. Researchers evaluated follow-up data from the Nurse's Health Study collected from 1980 through 2008. The women in the study were 30 to 55 years old in 1976. Overall, the risk for breast cancer was 88 percent higher among women who had taken estrogen plus progesterone for 10 to 14.9 years, compared to women who did not. This risk more than doubled for women who used ... Read more
Related support groups: Breast Cancer, Estradiol, Premarin, Estrace, Vivelle, Climara, Vagifem, Estrace Vaginal Cream, Ethinyl Estradiol, Estring, Vivelle-Dot, Evamist, Estradiol Patch, Premarin Vaginal, Enjuvia
FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause
Posted 2 Dec 2009 by Drugs.com
PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ – Novo Nordisk said today that the U.S. Food and Drug Administration (FDA) has approved a 10 mcg dose formulation of Vagifem (estradiol vaginal tablets) for the treatment of atrophic vaginitis due to menopause - a condition experienced by up to 75 percent of postmenopausal women. This approval makes Vagifem 10 mcg the lowest local estrogen therapy (LET) dose commercially available in the U.S. It will be available in pharmacies in the first quarter of 2010. Atrophic vaginitis, commonly referred to as vaginal atrophy, is directly related to the loss of estrogen associated with menopause. It is caused by the resulting thinning and shrinking of vaginal tissues and the decreased lubrication of the vaginal walls, which can lead to vaginal dryness, soreness, vaginal and or vulvar itching and irritation, painful sexual intercourse and light ... Read more
Related support groups: Vagifem, Atrophic Vaginitis, Menopause Support, Estradiol Topical, Menopause